Dominic L. Li

458 total citations
7 papers, 330 citations indexed

About

Dominic L. Li is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Dominic L. Li has authored 7 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 3 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Dominic L. Li's work include Pain Mechanisms and Treatments (3 papers), Stress Responses and Cortisol (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Dominic L. Li is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Stress Responses and Cortisol (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Dominic L. Li collaborates with scholars based in United States, France and Italy. Dominic L. Li's co-authors include Smriti Iyengar, Rosa Maria A. Simmons, Paul L. Ornstein, Ken H. Hoo, Tiziana Bisogno, Eleni T. Tzavara, Bruno Giros, Lee A. Phebus, George G. Nomikos and Vincenzo Di Marzo and has published in prestigious journals such as Biological Psychiatry, Brain Research and Pain.

In The Last Decade

Dominic L. Li

7 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominic L. Li United States 7 205 123 110 90 31 7 330
C.A. da-Silva Brazil 13 222 1.1× 99 0.8× 111 1.0× 66 0.7× 20 0.6× 15 448
Patrizia Oliva Italy 8 234 1.1× 87 0.7× 249 2.3× 100 1.1× 26 0.8× 9 401
Mati Lopez‐Grancha Spain 9 113 0.6× 114 0.9× 46 0.4× 97 1.1× 24 0.8× 11 331
Michio Kawahara Japan 12 226 1.1× 82 0.7× 87 0.8× 106 1.2× 18 0.6× 22 439
Kim L. Matthews United Kingdom 9 136 0.7× 196 1.6× 123 1.1× 53 0.6× 27 0.9× 14 453
Srinivas Gullapalli India 12 126 0.6× 161 1.3× 92 0.8× 75 0.8× 15 0.5× 19 416
Ryszard Szkilnik Poland 12 140 0.7× 79 0.6× 70 0.6× 29 0.3× 26 0.8× 64 382
Jéssica Ruiz‐Medina Spain 12 171 0.8× 128 1.0× 102 0.9× 68 0.8× 22 0.7× 13 388
Bernadett K. Szász Hungary 10 212 1.0× 153 1.2× 70 0.6× 72 0.8× 17 0.5× 11 361
Dingge Li United States 13 230 1.1× 163 1.3× 172 1.6× 39 0.4× 68 2.2× 16 474

Countries citing papers authored by Dominic L. Li

Since Specialization
Citations

This map shows the geographic impact of Dominic L. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominic L. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominic L. Li more than expected).

Fields of papers citing papers by Dominic L. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominic L. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominic L. Li. The network helps show where Dominic L. Li may publish in the future.

Co-authorship network of co-authors of Dominic L. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dominic L. Li. A scholar is included among the top collaborators of Dominic L. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominic L. Li. Dominic L. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Johnson, Michael P., Mark Muhlhauser, Eric S. Nisenbaum, et al.. (2017). Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models. British Journal of Pharmacology. 174(9). 822–835. 18 indexed citations
2.
Tzavara, Eleni T., Dominic L. Li, Tiziana Bisogno, et al.. (2005). Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications. Biological Psychiatry. 59(6). 508–515. 104 indexed citations
3.
Heinrichs, Stephen C., Dominic L. Li, & Smriti Iyengar. (2001). Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats. Brain Research. 900(2). 177–185. 33 indexed citations
4.
Shannon, Harlan E., Carrie K. Jones, Dominic L. Li, et al.. (2001). Antihyperalgesic effects of the muscarinic receptor ligand vedaclidine in models involving central sensitization in rats. Pain. 93(3). 221–227. 10 indexed citations
5.
Simmons, Rosa Maria A., et al.. (1998). Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology. 37(1). 25–36. 137 indexed citations
6.
Li, Dominic L., Rosa Maria A. Simmons, & Smriti Iyengar. (1998). 5HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding. Brain Research. 781(1-2). 121–128. 14 indexed citations
7.
Li, Dominic L., et al.. (1988). Probucol enhances cholesterol transport in cultured rat hepatocytes. The American Journal of Cardiology. 62(3). B52–B56. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026